BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11081445)

  • 1. Role of plaque rupture in acute coronary syndromes.
    Forrester JS
    Am J Cardiol; 2000 Oct; 86(8B):15J-23J. PubMed ID: 11081445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization.
    Libby P
    Am J Cardiol; 2000 Oct; 86(8B):3J-8J; discussion 8J-9J. PubMed ID: 11081443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-lowering therapies in the management of acute coronary syndromes.
    Mosca L; Biviano A;
    Curr Cardiol Rep; 2002 Jul; 4(4):320-6. PubMed ID: 12052271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early use of statins in acute coronary syndromes.
    Spin JM; Vagelos RH; ;
    Curr Cardiol Rep; 2002 Jul; 4(4):289-97. PubMed ID: 12052268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of statins in acute coronary syndromes: the mechanisms behind the outcomes.
    Plana JC; Jones PH
    Curr Atheroscler Rep; 2001 Sep; 3(5):355-64. PubMed ID: 11487446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy and the management of acute coronary syndromes.
    Langer A; Constance C; Fodor JG; Frohlich JJ; Grégoire J; Lau DC; Leiter LA; Mancini GB; Marr D; McPherson R; O'Neill BJ; Rabkin SW
    Can J Cardiol; 2003 Jul; 19(8):921-7. PubMed ID: 12876613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of different lipid-lowering strategies on plaque volume and plaque composition in patients with coronary artery disease: role of intravascular ultrasound imaging.
    Bocksch W; Fateh-Moghadam S; Huehns S; Schartl M
    Kidney Blood Press Res; 2005; 28(5-6):290-4. PubMed ID: 16534223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy.
    Kinlay S; Ganz P
    Am J Cardiol; 2000 Oct; 86(8B):10J-13J; discussion 13J-14J. PubMed ID: 11081444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of statins in acute coronary syndromes.
    Foody JM; Nissen SE
    Am J Cardiol; 2001 Aug; 88(4A):31F-5F. PubMed ID: 11520485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to achieve coronary arterial plaque stabilization.
    Rabbani R; Topol EJ
    Cardiovasc Res; 1999 Feb; 41(2):402-17. PubMed ID: 10341840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of lipid management in acute coronary syndrome.
    Fujisue K; Tsujita K
    J Cardiol; 2017 Aug; 70(2):101-106. PubMed ID: 28325524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The relationship between clinical events and the angiographic lesions in coronary atherosclerosis. Hypolipemic treatment and plaque stabilization].
    Castro Beiras A; Vázquez Rodríguez JM; Muñiz J; Calviño R; Vázquez González N; Juane R
    Rev Esp Cardiol; 1995; 48 Suppl 5():23-30. PubMed ID: 7494936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol lowering and the vessel wall: new insights and future perspectives.
    Stulc T; Ceska R
    Physiol Res; 2001; 50(5):461-71. PubMed ID: 11702850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].
    Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthy ageing: addressing acute coronary syndrome?
    Gaw A
    Eur Heart J; 2001 Nov; 3 Suppl N():N11-5. PubMed ID: 11913484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic prevention of coronary artery disease. What do clinical trials show?
    Milani RV; Lavie CJ
    Postgrad Med; 1996 Feb; 99(2):109-12, 115-20. PubMed ID: 8632961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study.
    Kuroda M; Shinke T; Sakaguchi K; Otake H; Takaya T; Hirota Y; Sugiyama D; Nakagawa M; Hariki H; Inoue T; Osue T; Taniguchi Y; Iwasaki M; Nishio R; Kinutani H; Konishi A; Hiranuma N; Takahashi H; Terashita D; Hirata KI
    JACC Cardiovasc Interv; 2015 May; 8(6):800-811. PubMed ID: 25999102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future treatment of hyperlipidemia: the role of statins.
    Farnier M; Davignon J
    Am J Cardiol; 1998 Aug; 82(4B):3J-10J. PubMed ID: 9737640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Going from immutable to mutable atherosclerotic plaques.
    Davies MJ
    Am J Cardiol; 2001 Aug; 88(4A):2F-9F. PubMed ID: 11520480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.
    Koh KK
    Cardiovasc Res; 2000 Sep; 47(4):648-57. PubMed ID: 10974215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.